I.R.C.C.S. Fondazione Santa Lucia
Roma, Italy, 00179
NCT Number: NCT06776978
This clinical trial investigated whether transcranial direct current stimulation (tDCS) over Broca's area (F5) could improve verb naming abilities in adults with aphasia. Additionally, the study evaluated the stability of the treatment response to tDCS over time.
The main questions this study sought to answer were:
* Does tDCS improve verb naming abilities compared to inactive (sham) stimulation? * Are the observed effects stable over time?
Participants received 10 daily sessions of tDCS over two consecutive weeks (5 days per week). The study included two treatment conditions, separated by one-month washout period:
* Active tDCS: Stimulation over Broca's area at 2 mA; * Sham tDCS: Stimulation mimicking the active condition without delivering electrical current.
During the treatment, participants were asked to name aloud videos of actions displayed on a computer screen. One month after each treatment condition, follow-up testing was conducted to evaluate the stability of the treatment response.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Roma, Italy, 00179
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants receive anodic tDCS using a battery-driven Eldith (neuroConn GmbH) Programmable Direct Current Stimulator with surface-soaked sponge electrodes (5×7 cm). A constant current of 2 mA is applied for 20 minutes per session. The stimulation targets the left frontal region (F5 of the extended International 10-20 EEG system), corresponding to Broca's area, while the reference electrode is placed over the contralateral frontopolar cortex. tDCS is performed for 10 daily sessions over two consecutive weeks (5 days per week).
Participants receive sham tDCS using a battery-driven Eldith (neuroConn GmbH) Programmable Direct Current Stimulator with surface-soaked sponge electrodes (5×7 cm). No therapeutic current is applied during the 20-minute session. The electrode placement mimics the active condition, targeting the left frontal region (F5 of the extended International 10-20 EEG system), corresponding to Broca's area, while the reference electrode is placed over the contralateral frontopolar cortex. Sham tDCS is performed for 10 daily sessions over two consecutive weeks (5 days per week).
Time frame: Verb naming performance was assessed at baseline (pre-treatment), post-treatment (immediately after the 10-day intervention), and at follow-up (one month after each treatment condition) to evaluate both immediate effects and the stability of responses.
An action naming task was designed to evaluate verb naming performance. Video clips depicting various actions were presented on a 15-inch computer screen at a viewing distance of 1 meter, each preceded by an 800-millisecond fixation point. Participants were instructed to name the action depicted in each clip within a 15-second response window. The examiner manually recorded correct responses. For incorrect responses or failures to respond within the allotted time, the written name of the action was displayed beneath the video, and participants were required to read the name aloud. The video and the written name remained on the screen until the word was read correctly or 40 seconds had elapsed. The task was conducted during 20-minute tDCS sessions, wherein participants received either active stimulation targeting Broca's area or sham stimulation with identical electrode placement but no active current.
I.R.C.C.S. Fondazione Santa Lucia
Other
La Stimolazione Transcranica (tDCS) E Transpinale a Corrente Diretta (tsDCS) Per Il Recupero Delle Funzioni Cognitive in Soggetti Affetti Da Patologia Cerebrovascolare O Neurodegenerativa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04364854
Aphasia, Aphasia Non Fluent
Charleston, South Carolina, United States
View Trial DetailsNCT06829420
Aphasia, Aphasia Non Fluent
Tampa, Florida, United States
View Trial DetailsNCT07036406
Anomia, Aphasia
New York, United States
View Trial DetailsNCT05303649
Aphasia, Aphasia Non Fluent
Warsaw, Masovian Voivodeship, Poland
View Trial Details